Compound ID | 1034

Verdamicin

Synonym(s): Verdamycin

Class: Aminoglycoside

Institute where first reported: Schering Corp., Bloomfield
Year first mentioned: 1993
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Canonical SMILES: C[C@@H](C1=CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@](C)(CO3)O)NC)O)N)N)N)N
Isomeric SMILES: C[C@@H](C1=CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)N
InChI: InChI=1S/C20H39N5O7/c1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19/h5,8-11,13-19,25-28H,4,6-7,21-24H2,1-3H3/t8-,9+,10-,11+,13-,14+,15+,16-,17+,18+,19+,20-/m0/s1
InChI Key: XUSXOPRDIDWMFO-CTMSJIKGSA-N
Structure link: https://pubchem.ncbi.nlm.nih.gov/compound/512877
External links:
Guide to Pharmacology: verdamicin
Citation: http://aac.asm.org/content/7/3/246.abstract

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us.

Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.